Evidence map›Paper›PMID 42058404›Full record

ArticleFrontiers in medicine2026

Case report of a fatal probable catastrophic antiphospholipid syndrome.

Sheng-Jie Hou, Ming-Xin Xie, Xuanlin Feng, Hua Jiang, Ping Zhou

Abstract readCase Reports
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sheng-Jie Hou *School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Ming-Xin Xie *Department of Emergency Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Xuanlin FengDepartment of Emergency Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Hua JiangSchool of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Ping ZhouSchool of Medicine, University of Electronic Science and Technology of China, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Catastrophic antiphospholipid syndrome (CAPS) is an uncommon but often fatal manifestation of antiphospholipid syndrome, marked by rapid, diffuse microvascular thrombosis with multiorgan involvement. In practice, the initial clinical picture can be indistinguishable from severe infection or sepsis-associated organ failure, which makes early diagnosis challenging. Early recognition is critical, as delayed intervention is associated with high mortality. We report a case of probable CAPS that presented with splenic infarction and shock in the setting of suspected sepsis. Her condition progressed quickly to multiorgan dysfunction, and antiphospholipid antibody testing repeatedly showed high-titer triple positivity. After probable CAPS was considered, triple therapy (high-dose glucocorticoids, anticoagulation, and therapeutic plasma exchange) was initiated, and she was discharged after clinical stabilization. She was later readmitted with fulminant infection and recurrent CAPS-like manifestations. Anticoagulation and plasma exchange were not restarted, and she died within 72 h, highlighting two contrasting courses under diagnostic uncertainty.

Indexed as

antiphospholipid antibodiescatastrophic antiphospholipid syndrome (CAPS)infection-triggered CAPS-like episodesplenic infarctiontherapeutic plasma exchange (TPE)

Identifiers

PMID42058404
PMCPMC13121309

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.